| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/17/2008 | EP2002825A1 Pharmaceutical compositions comprising orlistat |
| 12/17/2008 | EP2002734A1 Carbohydrate composition obtainable from mediterranean fruits |
| 12/17/2008 | EP2002729A1 Use of pinolenic acid for lowering cholesterol |
| 12/17/2008 | EP2001879A1 Azolopyridin-3-one derivatives as inhibitors of endothelial lipase |
| 12/17/2008 | EP2001878A1 Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase |
| 12/17/2008 | EP2001875A2 Glucokinase activators |
| 12/17/2008 | EP2001844A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders |
| 12/17/2008 | EP2001842A2 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| 12/17/2008 | EP2001841A2 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof |
| 12/17/2008 | EP2001833A1 Anti-diabetic cataract compounds and their uses |
| 12/17/2008 | EP2001485A2 Diazepan orexin receptor antagonists |
| 12/17/2008 | EP2001470A2 Combination therapies of thiazolidinedione analogues |
| 12/17/2008 | EP2001469A2 Thiazolidinedione analogues |
| 12/17/2008 | EP2001468A2 Thiazolidinedione analogues |
| 12/17/2008 | EP1773829B1 Amino-tropane derivatives, preparation thereof and therapeutic use thereof |
| 12/17/2008 | EP1753736B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 12/17/2008 | EP1651623B1 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 12/17/2008 | EP1638937B1 Fluvastatin sodium crystal form xiv, processes for preparing it, compositions containing it and methods of using it |
| 12/17/2008 | EP1628622A4 Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements |
| 12/17/2008 | EP1559703B1 A natural compound useful for treating diabetes, its preparation and use |
| 12/17/2008 | EP1536778B1 Proteins binding to cross-beta structure comprising amyloid and methods for modulation of the cross-beta structure, its formation and its associated toxicity |
| 12/17/2008 | EP1503772B1 Soluble composition containing sporopollenin and the use thereof |
| 12/17/2008 | EP1423106B1 Arylsulfonyl derivatives with 5-ht 6 receptor affinity |
| 12/17/2008 | EP1377284B1 Controlled release arginine formulations |
| 12/17/2008 | EP1369119B1 Il-12 expression controlling agents |
| 12/17/2008 | EP1330244B1 Compositions comprising modafinil compounds |
| 12/17/2008 | EP1274449B1 Methods for manipulating upper gastrointestinal transit, blood flow, for inducing satiety |
| 12/17/2008 | EP1255742B1 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors |
| 12/17/2008 | EP1251738B1 Novel diphenylethylene compounds |
| 12/17/2008 | EP1230214B1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 12/17/2008 | EP1077943B1 Heterocyclic inhibitors of p38 |
| 12/17/2008 | CN101326187A Pyrrolo[2,3-c]pyridine derivatives |
| 12/17/2008 | CN101326181A Imidazopyridine derivatives as a2b adenosine receptor antagonists |
| 12/17/2008 | CN101326179A New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 12/17/2008 | CN101326177A Dihydroisoindolones as allosteric modulators of glucokinase |
| 12/17/2008 | CN101326173A Thiadiazoles derivant as anti-diabetes agent |
| 12/17/2008 | CN101326166A Novel N-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions |
| 12/17/2008 | CN101325951A Leucine rich composition |
| 12/17/2008 | CN101325881A Equol-containing fermentation product of soybean embryonic axis, and method for production thereof |
| 12/17/2008 | CN101323850A Lactobacillus helveticus microcapsule, preparation and use thereof |
| 12/17/2008 | CN101323640A Enzymolysis product inhibiting alpha-glucosidase activity and use thereof |
| 12/17/2008 | CN101323613A Berberine additive product, medicament containing the same and preparation thereof |
| 12/17/2008 | CN101323604A Novel PPAR alpha/beta dual agonist, preparation and use thereof |
| 12/17/2008 | CN101322840A Human cystathionine beta-synthetase recombinant protein and use |
| 12/17/2008 | CN101322767A Combination specific to valid target for treating diabetic and use thereof |
| 12/17/2008 | CN101322762A Medicinal composition for treating diabetes |
| 12/17/2008 | CN101322757A Medicament composition for treating diabetes and method for preparing the same |
| 12/17/2008 | CN101322739A Prescription of Chinese medicine health care capsules mixed with nucleotide and aminoacid and preparing technique |
| 12/17/2008 | CN101322738A Preparation of red sandalwood extract for treating diabetic and uses thereof |
| 12/17/2008 | CN101322737A Persimmon leaf flavones extract and preparation thereof |
| 12/17/2008 | CN101322731A Capsule for protecting eye and lowering blood sugar |
| 12/17/2008 | CN101322730A Method for processing blackcurrant seed |
| 12/17/2008 | CN101322698A Applications of betaine in preparing medicament for preventing and treating alimentary obesity |
| 12/17/2008 | CN101322574A Powdered beverage composition |
| 12/17/2008 | CN101322571A Method for producing coffee-imitating effervescence hypoglycemic drink from Arctium lappa and bitter melon |
| 12/17/2008 | CN101322570A Process for preparing acanthopanax root drink |
| 12/17/2008 | CN101322556A Tibetan medicine anti-fatigue anoxia-tolerance drink |
| 12/17/2008 | CN101322553A Food prescription for reducing blood fat and processing technique thereof |
| 12/17/2008 | CN101322552A Food prescription for regulating blood sugar and processing technique thereof |
| 12/17/2008 | CN101322534A Method for producing dried shaddock with function of repairing islet cells |
| 12/17/2008 | CN101322514A Green tea Ganoderma lucidum drink and preparation method thereof |
| 12/17/2008 | CN100443496C A-decarbon-5 alpha-androstane-2-one-17 beta-alcohol ester and its prepn and use |
| 12/17/2008 | CN100443494C 2-phenoxy chromone heteroside compounds and its preparing method and use |
| 12/17/2008 | CN100443485C Derivative of soldium iron chlorophyllin, preparation method and application |
| 12/17/2008 | CN100443481C Imidazolyl-cyclic acetals |
| 12/17/2008 | CN100443479C 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 12/17/2008 | CN100443477C Substituted benzoxazoles and analogues as estrogenic agents |
| 12/17/2008 | CN100443084C Alprostadil preparation and its making method |
| 12/16/2008 | US7465815 Cannabinoid receptor modulator |
| 12/16/2008 | US7465751 respiratory, urinary and gastrointestinal systems disorders; 2-cyclopentyl-2-hydroxy-N-[(3S)-1-benzyl-pyrrolidin-3-yl]-2-phenyl acetamide; side effects reduction; compounds exhibit significant potency |
| 12/16/2008 | US7465741 selective serotonine (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenocptor antagonist activity; To treat anxiety, movement disorders, psychosis, Parkinson's disease and body weight disorders including anorexia nervosa and bulimia without being sedative |
| 12/16/2008 | US7465737 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl -6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 12/16/2008 | US7465736 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 12/16/2008 | US7465713 human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; antidiabetic and hyperglycemic agents; obesity; 3-(6-O-ethoxycarbonyl- beta -D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methy]-1-isopropyl-5-methylpyrazole |
| 12/16/2008 | US7465712 Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives |
| 12/16/2008 | US7465467 Process for the extraction, purification and enzymatic modification of soy 7S globulin α' subunit for use as hypocholesterolemizing agent |
| 12/16/2008 | CA2295519C A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
| 12/16/2008 | CA2285242C Mixture of primary fatty acids obtained from sugar cane wax |
| 12/16/2008 | CA2254975C Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells |
| 12/16/2008 | CA2142678C Enteral composition comprising native micellar casein |
| 12/13/2008 | CA2634563A1 Carbohydrate composition obtainable from mediterranean fruits |
| 12/11/2008 | WO2008150486A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 12/11/2008 | WO2008150212A1 A method for modifying polyphenol containing plant materials and medical uses of modified polyphenol plant containing materials |
| 12/11/2008 | WO2008150191A1 Anorexigenic medicinal agent for controlling the body mass |
| 12/11/2008 | WO2008150074A2 The composition comprising the extracts, fractions and the isolated compounds of rhus verniciflua for prevention and treatment of diabetic complications |
| 12/11/2008 | WO2008149994A1 Tympanites ventriculi-controlling agent for ruminant animals |
| 12/11/2008 | WO2008149992A1 Lumen fermentation improving agent |
| 12/11/2008 | WO2008149802A1 Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient |
| 12/11/2008 | WO2008149689A1 Composition having antioxidative activity |
| 12/11/2008 | WO2008149688A1 Composition having antioxidative activity |
| 12/11/2008 | WO2008149382A1 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 12/11/2008 | WO2008149379A2 Novel compounds |
| 12/11/2008 | WO2008149283A1 Composition for supressing appetite, improving tone and mood, with a natural antidepressant activity and with an antiasthenic effect |
| 12/11/2008 | WO2008149181A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
| 12/11/2008 | WO2008149177A2 Marine lipid compositions and uses thereof |
| 12/11/2008 | WO2008148868A1 Piperidine/piperazine derivatives |
| 12/11/2008 | WO2008148867A2 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 12/11/2008 | WO2008148849A2 Piperidine/piperazine derivatives |
| 12/11/2008 | WO2008148840A1 Piperidine/piperazine derivatives |
| 12/11/2008 | WO2008148839A2 Long-acting polymeric prodrugs of exendin |